COURTNEY FULLMER: Open Payments
NPI 1114508058 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,663 in 30 payments from 14 companies in 2025. Trend: 2023 $727 · 2024 $3,505 · 2025 $1,663
Speaker / faculty: $1,250Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $1,360 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Lundbeck LLC | 2 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: VRAYLAR, Auvelity, FANAPT, COBENFY, REXULTI, INGREZZA, TRINTELLIX, Jornay PM.
Industry payments across IN — which companies pay providers there.
